Curcumin effect in patients with type 2 diabetes mellitus and co-existent dislipidemia

Phase 3

Recruiting

Conditions: patients with type 2 diabetes mellitus and co-existence dislipidemia.
Type 2 diabetes mellitus with other specified complication
E11.69

Registration Number: IRCT20130408012941N2

Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 80

Inclusion Criteria

Patients with with type 2 diabetes mellitus based on FPG= 126 mg/dL, glycated hemoglobin (HbA1C) = 6.5% OR treatment with antidiabetic drugs.
Co-existence of dislipidemia
Patient consent to participate in the study

Exclusion Criteria

Pregnancy and breast feeding
Malignancy
Chronic liver dysfunction (alt,ast >3 fold more than normal)
Kidny dysfunction (cr>2)
Chronic inflammatory diseases
Acute infection diseases
Endocrine diseases
Psychology diseases
Secondary causes of hypoglycemia
Drug use
Change the antidiabetic drugs
Obstructive billiary and liver diseases
History of gallbladder stones

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Fasting blood sugar. Timepoint: before intervention and 12 weeks after intervention. Method of measurement: Lab test on blood sample.;LDL (low-density lipoprotein). Timepoint: before intervention and 12 weeks after. Method of measurement: Lab test on blood sample.;Hemoglobin A1C. Timepoint: before intervention and 12 weeks after. Method of measurement: Lab test on blood sample.;HDL (High-density lipoprotein). Timepoint: before intervention and 12 weeks after. Method of measurement: Lab test on blood sample.;TG (Triglyceride). Timepoint: before intervention and 12 weeks after. Method of measurement: Lab test on blood sample.;Total Cholesterol. Timepoint: before intervention and 12 weeks after. Method of measurement: Lab test on blood sample.

Secondary Outcome Measures